Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World ExperienceBusiness Wire • 09/02/26
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey FindsBusiness Wire • 09/01/26
Bausch + Lomb Corporation (BLCO) Discusses Results and Development Plans for Dual Action Dry Eye Medicine and Lead Ocular Surface Pain Candidate TranscriptSeeking Alpha • 08/25/26
Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib GoalMarketBeat • 08/25/26
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 GuidanceBusiness Wire • 07/29/26
Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S.Zacks Investment Research • 07/20/26
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United StatesBusiness Wire • 07/16/26
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective CandidateBusiness Wire • 07/09/26
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient CareBusiness Wire • 07/09/26
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-ConfidenceBusiness Wire • 07/01/26
Bausch + Lomb Corporation (BLCO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care TranscriptSeeking Alpha • 06/01/26
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United StatesBusiness Wire • 06/01/26
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare ConferenceBusiness Wire • 05/21/26
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win24/7 Wall Street • 05/13/26